

In Sensory Integration therapy, physical tactile input is a primary clinical requirement, not an optional supplement. Fabtive provides the essential remote interface that enables therapists to deliver this input outside the clinic
Digital health is currently sight and sound only. We are bringing the 3rd dimension-Touch-into the clinical loop.
40% of therapy effectiveness is lost due to the absence of physical-clinical connection between clinics and patients' homes.
(50-70)% - Non-adherence to Home Exercise Programs(HEP)
Touch remains the only human sense that cannot be objectively measured or delivered remotely, creating a significant "Tangibility Gap" in digital healthcare. Plectrum bridges this gap by transforming tactile intervention into a quantifiable, clinical-grade digital modality.
A proprietary Active Fabric interface that delivers precise, software-controlled physical input directly to the skin. This AI-powered platform enables professional-grade Sensory Integration outside the clinic, providing real-time, adaptive regulation for individuals with ASD and SPD.
Bypassing traditional clinic bottlenecks by deploying a direct-to-payer virtual clinic model. This ensures rapid expansion and continuous care delivery across any patient population, regardless of physical infrastructure.
Transforming subjective sensory experiences into actionable data, providing therapists and payers with measurable progress reports.
Synchronizing biometric response with automated regulation protocols to ensure the therapy is always precise and adaptive.
Turning Subjective Experiences into Objective Clinical Outcomes
Capture objective biometric and response data directly from the FABTIVE wearable
Ai-driven algorithms formulate a personalized sensory regulation protocol in real time
Deliver targeted, sotware-controlled Active Tactile Intervention.
Automated CPT 97533 Documentation
A data-driven cycle designed to prevent sensory meltdowns and reduce acute healthcare costs.
Full-torso deep pressure & regulation
up to 24 tactile points.
Cranial sensory modulation for crisis prevention.
Targeted limb regulation for localized sensory input.
up to 24 tactile points.
High-definition tactile stimulation for fine motor support
*. Images are for illustrative purposes only. Final product design may vary.
The Plectrum software ecosystem provides a seamless bridge between clinical intent and physical intervention. Designed for cross-platform versatility, the application is fully optimized for Android and Windows OS, ensuring high-performance control across PCs, tablets, and mobile devices. For next-generation immersion, the platform features native XR (Extended Reality) integration, allowing haptic protocols to synchronize with virtual therapeutic environments.




*. Images are for illustrative purposes only. Final product design may vary.
A dual-code strategy ensuring stable, multi-payer reimbursement coverage.
Enabling immediate market deployment by bypassing Class II 510(k) clearance delays. This streamlined regulatory path, combined with our scalable B2B2C model, ensures a rapid Time-to-Market (TTM) and sustainable growth through existing clinical networks.
4 working prototypes integrated with SDK support for Android, Windows, and XR ecosystems
LOI with Hadassah Medical Center for clinical validation; NDAs signed with industry leaders NILIT and Delta Galil
Recruiting leading institutions in the US, Israel, and Europe to validate remote sensory integration outcomes
Graduated Hadassah/IBM Accelerator
FDA Class I Therapeutic Vibrator Listing
Clinical Validation & Strategic Pilots
U.S. Commercial Deployment
*. FDA Class I: 21 CFR 890.5975 - No 510(k) required for immediate market entry.
Join our Clinical Pilot Program (2026) We are inviting leading pediatric OT clinics and rehabilitation centers to integrate Plectrum’s "Active Fabric" technology into their practice. Be at the forefront of the shift from clinic-bound therapy to continuous, data-driven home intervention.
Why Collaborate?

or Scan the QR Code to join our journey

We're seeking strategic investors to accelerate clinical validation, scale production, and capture the massive $405M Remote Sensory Integration market opportunity. Your investment will fund critical clinical trials, regulatory approvals, and initial market deployment.

+972-52-680-8756
gabriel@plectrum.biz

©2026 by Plectrum.
Bridging the Tangibility